Abstract
The aim of this study was to investigate whether anticoagulant and antiaggregant agents have protective effects against oxidative damage induced by peripheral ischemia-reperfusion (I/R). Groups were created as follows: control group, I/R group (sham group), I/R plus acetylsalicylic acid (Group I), I/R+clopidogrel (Group II), I/R+rivaroxaban (Group III), I/R+bemiparin sodium (Group IV), and I/R+enoxaparin sodium (Group V). In Groups I, II, III, IV, and V, drugs were administered daily for 1 week before I/R creation. Peripheral I/R was induced in the I/R groups by clamping the right femoral artery. The rats were sacrificed 1 hour after reperfusion. Nitrogen oxide levels, malondialdehyde (MDA) levels, paraoxonase-1 (PON1) activity, and prolidase activity were evaluated in both cardiac and renal tissues. There was no significant difference in nitrogen oxide levels between the groups. However, cardiac and renal MDA were significantly higher and PON1 activity was markedly lower in the I/R groups compared with the control group (p<0.05). Although elevated prolidase activity was detected in both the cardiac and renal tissue of the I/R groups, only the sham group and Group V had significantly higher renal prolidase activity (p<0.05). Gr...Continue Reading
References
Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Oct 27, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·I MyaraA Lemonnier
Dec 1, 1995·Human Reproduction·M HignettP Claman
Oct 29, 1998·Biochemical and Biophysical Research Communications·A KimuraR J Bing
Mar 2, 2002·European Journal of Clinical Pharmacology·J P de la CruzF Sánchez de la Cuesta
Oct 17, 2002·Acta neurochirurgica·C TopsakalF Gursu
Oct 30, 2003·Drug and Chemical Toxicology·Bahar UlubaşOzlem Bölgen Cimen
Dec 17, 2003·Molecular and Cellular Biochemistry·P R Deepa, P Varalakshmi
Jun 15, 2005·Medical Hypotheses·S AkyürekI L Atahan
May 6, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Thomas HeitzerStephan Baldus
Jun 15, 2006·Renal Failure·T Rifki EvrenkayaMustafa Gultepe
Aug 8, 2006·Journal of Cardiovascular Pharmacology·Muhip KankoCigdem Acil
Jan 30, 2007·Pharmacology·Ileana ManduteanuMaya Simionescu
Dec 14, 2007·The Tohoku Journal of Experimental Medicine·Davut Keskin, Ahmet Kiziltunç
Jun 4, 2008·Journal of Lipid Research·Priscilla JaichanderSampath Parthasarathy
Mar 21, 2009·Seminars in Vascular Surgery·Jessica Beth O'Connell, William J Quiñones-Baldrich
May 25, 2011·Thrombosis Research·Omer Tamer DoganAli Cetin
Jun 2, 2011·The Journal of Pathology·Honglin HuCarole Nicco
Aug 30, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Željko ŽupanGordana Župan
Oct 15, 2011·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Egemen CebeciMecdi Erguney
Oct 20, 2011·Journal of Thrombosis and Haemostasis : JTH·A D TselepisI A Goudevenos
Apr 19, 2012·The Medical Journal of Australia·J Alasdair MillarIan K Densie
Jun 23, 2012·Cardiology·Arlene Bradley LevineT Barry Levine
Nov 21, 2012·Clinical Endocrinology·Nese HilaliNurten Aksoy
Jan 15, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Celal YavuzBinali Mavitas
Apr 1, 2011·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Mohammed A Taher, Eman S Nassir
Sep 13, 2013·Perfusion·A CaliskanB Mavitas
Nov 13, 2013·Journal of Thrombosis and Thrombolysis·Ahmet CaliskanBinali Mavitas
Citations
Jan 13, 2018·BMC Pharmacology & Toxicology·Reem Ali ShakerNajah Hadi
Sep 4, 2020·Vascular and Endovascular Surgery·Ömer Faruk GülaştıHale Maral Kır
Aug 21, 2019·International Journal of Molecular Sciences·Afonso Caricati-NetoFrancisco Sandro Menezes-Rodrigues
Aug 22, 2017·Frontiers in Cardiovascular Medicine·Adnan SultanAndrew P DeFilippis
Nov 18, 2020·Canadian Journal of Physiology and Pharmacology·Badegül SarikayaLamia Pinar
Mar 10, 2019·World Neurosurgery·Pınar Aydin OzturkUnal Ozturk